Prevalence of vitamin K deficiency in cystic fibrosis

American Journal of Clinical Nutrition

Volumn 70, Issue 3, 1999, Pages 378-382

  Rashid, Mohsin ^b   Durie, Peter ^b   Andrew, Maureen ^b   Kalnins, Daina ^b   Shin, Janey ^b   Corey, Mary ^b   Tullis, Elizabeth ^b   Pencharz, Paul B ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE

Author keywords

Cystic fibrosis; Cystic fibrosis associated liver disease; PIVKA II; Prothrombin; Vitamin K; glutamyl hydrolase

Indexed keywords

PROTHROMBIN; VITAMIN K GROUP;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; HEPATOBILIARY DISEASE; HUMAN; INFANT; MAJOR CLINICAL STUDY; PANCREAS INSUFFICIENCY; PREVALENCE; RISK FACTOR; VITAMIN K DEFICIENCY;

EID: 0032865465     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/70.3.378     Document Type: Article

References (36)

1. Sokol RJ, Reardon MC, Accurso FJ, et al. Fat-soluble-vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns. Am J Clin Nutr 1989;50:1064-71.
2. Congden PJ, Bruce G, Rothburn MM, et al. Vitamin status in treated patients with cystic fibrosis. Arch Dis Child 1981;56:708-14.
3. Dowd P, Ham S, Naganathan S, Hershlin R. The mechanism of action of vitamin K. Annu Rev Nutr 1995;15:419-40.
4. Sokoll LJ, Sadowski JA. Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population. Am J Clin Nutr 1996;63:566-73.
5. Bach AU, Anderson SA, Foley AL, Williams EC, Suttie JW. Assessment of vitamin K status in human subjects administered "minidose" warfarin. Am J Clin Nutr 1996;64:894-902.
6. Shearer MJ. Vitamin K. Lancet 1995;345:229-34.
7. Ferland G, Sadowski JA, O'Brien ME. Dietary induced subclinical vitamin K deficiency in normal human subjects. J Clin Invest 1993;91:1761-8.
8. Ramsey BW, Farrell PM, Pencharz PB. Nutritional support and management in cystic fibrosis: a consensus report. The Consensus Committee. Am J Clin Nutr 1992;55:108-16.
9. Durie PR. Vitamin K and the management of patients with cystic fibrosis. Can Med Assoc J 1994;151:933-6.
10. Corrigan JJ Jr, Taussig LM, Beckerman R, Wagener JS. Factor II (prothrombin) coagulant activity and immunoreactive protein: detection of vitamin K deficiency and liver disease in patients with cystic fibrosis. J Pediatr 1981;99:254-7.
11. 1 concentrations in cystic fibrosis. Arch Dis Child 1989;64:732-4.
12. Cornelissen EAM, van Lieburg AF, Motohara K, van Oostrom CG. Vitamin K status in cystic fibrosis. Acta Paediatr Scand 1992;81:658-61.
13. De Montalembert M, Lenoir G, Saint-Raymond A, Key J, Lefrere JJ. Increased PIVKA-II concentrations in patients with cystic fibrosis. J Clin Pathol 1992;45:180-1.
14. Beker LT, Ahrens RA, Fink RJ, et al. Effect of vitamin K supplementation on vitamin K status in cystic fibrosis patients. J Pediatr Gastroenterol Nutr 1997;24:512-7.
15. Vandekamer JH, Ten Bokkel Huinink H, Wyers HA. Rapid method for determination of fat in feces. J Biol Chem 1949;177:347-55.
16. Durie PR, Forstner GG, Gaskin KJ, et al. Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency. Pediatr Res 1986;20:209-13.
17. Grosley BM, Hirchauer C, Chamnbrette B, Bezeaud A, Amiral J. Specific measurement of hypocarboxylated prothrombin in plasma or serum and application to the diagnosis of hepatocellular carcinoma. J Lab Clin Med 1996;127:553-64.
18. Rudiger VK, Greer FR, Suttie JW. Assessment of vitamin K status of the newborn infant. J Paediatr Gastroenterol Nutr 1993;16:231-8.
19. Blanchard RA, Furie BC, Kruger SF, Waneck G, Jorgensen MJ, Furie B. Immunoassays of human prothrombin species which correlate with functional coagulant activities. J Lab Clin Med 1983;101:242-55.
20. Motohara K, Kuroki Y, Kan H, Endo F, Matsuda I. Detection of vitamin K deficiency by use of an enzyme linked immunosorbent assay for circulating abnormal prothrombin. Paediatr Res 1985;19:354-7.
21. Rucker RB. Improved functional endpoints for use in vitamin K assessment: important implications for bone disease. Am J Clin Nutr 1997;65:883-4.
22. Sokoll LJ, Sadowski JA. Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population. Am J Clin Nutr 1996;63:566-76.
23. Sokoll LJ, Booth SL, O'Brien ME, Davidson KW, Tsaioun KI. Sadowski JA. Changes in serum osteocalcin, plasma phylloquinone, and urinary γ-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. Am J Clin Nutr 1997;65:779-84.
24. Widdershoven J, van Munster P, De Abreu R, et al. Four methods compared for measuring des-carboxy prothrombin (PIVKA-II). Clin Chem 1987;33:2074-8.
25. Vermeer C, Jie KSG, Knapen MHJ. Role of vitamin K in bone metabolism. Annu Rev Nutr 1995;15:1-22.
26. Triffitt JT. The special proteins of bone tissue. Clin Sci 1987;72:399-408.
27. Knappen MHJ, Hamulyak K, Vermeer C. The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion. Ann Intern Med 1989;111:1001-5.
28. Hauschka PV, Lian JB, Cole DEC, Gundberg CM. Osteocalcin and matrix Gla protein: vitamin K dependent proteins in bone. Physiol Rev 1989;69:990-1047.
29. Maillard C, Berruyer M, Serre CM, Dechavanne M, Delmas PD. Protein-S, a vitamin K dependent protein, is a bone matrix component synthesized and secreted by osteoblasts. Endocrinology 1992;130:1599-604.
30. Rosen NH, Maitland LA, Suttie JW, Manning WJ, Glynn RJ, Greenspan SL. Vitamin K and maintenance of skeletal integrity in adults. Am J Med 1993;94:62-8.
31. Binkley NC, Suttie JW. Vitamin K nutrition and osteoporosis. J Nutr 1995;125:1812-21.
32. 2 concentrations in human liver associated with the use of broad spectrum antimicrobials. Clin Invest Med 1994;17:531-9.
33. Allison PM, Mummah-Schenedel LL, Kindberg CG, Harms CS, Bang NU, Suttie JW. Effects of a vitamin K-deficient diet and antibiotics in normal human volunteers. J Lab Clin Med 1987;110:180-8.
34. Suttie JW. The importance of menaquinones in human nutrition. Annu Rev Nutr 1995;15:399-417.
35. Blanchard RA, Furie BC, Jorgensen M, Kruger SF, Furie B. Acquired vitamin-dependent carboxylation dependent deficiency in liver disease. N Engl J Med 1981;305:242-8.
36. Grazi GL, Mazziotti A, Legnani C, et al. The role of tumor markers in the diagnosis of hepatocellular carcinoma with special reference to the des-gamma-carboxy prothrombin. Liver Transpl Surg 1995;1: 249-55.